Related references
Note: Only part of the references are listed.Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis
P. Serrano-Fernandez et al.
AUTOIMMUNITY (2010)
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
M. Comabella et al.
BRAIN (2009)
Absence of MxA induction by interferon β in patients with MS reflects complete loss of bioactivity
D. Hesse et al.
NEUROLOGY (2009)
Effect of neutralizing antibodies on biomarker responses to interferon beta The INSIGHT study
Andrew R. Pachner et al.
NEUROLOGY (2009)
Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a
Shaun Rosebeck et al.
APOPTOSIS (2008)
Sialic acid-binding Ig-like lectin I expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus
Robert Biesen et al.
ARTHRITIS AND RHEUMATISM (2008)
Increased expression of the type I interferon-inducible gene, lymphocyte antigen 6 complex locus E, in peripheral blood cells is predictive of lupus activity in a large cohort of Chinese lupus patients
J. Tang et al.
LUPUS (2008)
Pharmacogenomics of Interferon-β Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
Lisa G. M. van Baarsen et al.
PLOS ONE (2008)
G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells
Venugopalan Cheriyath et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I Interferons and Toll-like receptor agonists
Michael R. York et al.
ARTHRITIS AND RHEUMATISM (2007)
Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients
C. Gneiss et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Xuebing Feng et al.
ARTHRITIS AND RHEUMATISM (2006)
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Oxana A. Malakhova et al.
EMBO JOURNAL (2006)
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1
F Gilli et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
TRANSFAC (R) and its module TRANSCompel (R): transcriptional gene regulation in eukaryotes
V. Matys et al.
NUCLEIC ACIDS RESEARCH (2006)
G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell
E Tahara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Measurement of MxA mRNA or protein as a biomarker of IFNβ bioactivity -: Detection of antibody-mediated decreased bioactivity (ADB)
AR Pachner et al.
NEUROLOGY (2003)
Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patients
A Bertolotto et al.
NEUROLOGY (2003)
Protein ISGylation modulates the JAK-STAT signaling pathway
OA Malakhova et al.
GENES & DEVELOPMENT (2003)
Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-6I recognize two potential Ligands expressed by B lymphocytes
DL Pflugh et al.
JOURNAL OF IMMUNOLOGY (2002)
Interferon-induced mx proteins: Dynamin-like GTPases with antiviral activity
O Haller et al.
TRAFFIC (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1)
TK van den Berg et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
